Literature DB >> 19346254

Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation.

Tatiana Fila1, Stefania Trazzi, Christophe Crochemore, Renata Bartesaghi, Elisabetta Ciani.   

Abstract

The tumor suppressor gene Lot1 is highly expressed during brain development. During cerebellar development, Lot1 is expressed by proliferating granule cells with a time course matching the expression of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor, a neuropeptide receptor that plays an important role in the regulation of granule cell proliferation/survival. Although it has become clear that Lot1 is a negative regulator of cell division in tumor cells, its role in neuronal proliferation is not understood. We previously demonstrated that in cerebellar granule cells Lot1 expression is regulated by the PACAP/cAMP system. The aim of this study was to investigate the role played by Lot1 in neuron proliferation/survival and to identify the molecular mechanisms underlying its actions. Using a Lot1-inducible expression system, we found that in PC12 cells Lot1 negatively regulates proliferation and favors differentiation by up-regulating the expression of the PACAP receptor. In cerebellar granule cells in culture, an increase in Lot1 expression was paralleled by inhibition of proliferation and up-regulation of the PACAP receptor, which in turn positively regulated Lot1 expression. Silencing of Lot1 leads to an increase in granule cell proliferation and a reduction in survival. Confirming the in vitro results, in vivo experiments showed that PACAP induced an increase in Lot1 expression that was paralleled by inhibition of cerebellar granule cell proliferation. These data show that Lot1 is a key element of the PACAP/cAMP pathway that negatively regulates neuronal precursor proliferation. The existence of a PACAP receptor/Lot1-positive feedback loop may powerfully regulate neural proliferation during critical phases of cerebellar development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346254      PMCID: PMC2685713          DOI: 10.1074/jbc.M109.002329

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

Review 1.  Signal integration at the c-fos promoter.

Authors:  R Janknecht; M A Cahill; A Nordheim
Journal:  Carcinogenesis       Date:  1995-03       Impact factor: 4.944

2.  Activation of a reporter gene responsive to NGFI-B in cultured neurons and astrocytes.

Authors:  E Ciani; R E Paulsen
Journal:  J Mol Neurosci       Date:  1995       Impact factor: 3.444

3.  Pituitary adenylate cyclase-activating peptide stimulates neurite growth in PC12 cells.

Authors:  A Hernandez; B Kimball; G Romanchuk; M W Mulholland
Journal:  Peptides       Date:  1995       Impact factor: 3.750

4.  Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells.

Authors:  N Lu; E DiCicco-Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.

Authors:  S Cavallaro; A Copani; V D'Agata; S Musco; S Petralia; C Ventra; F Stivala; S Travali; P L Canonico
Journal:  Mol Pharmacol       Date:  1996-07       Impact factor: 4.436

6.  Integration of MAP kinase signal transduction pathways at the serum response element.

Authors:  A J Whitmarsh; P Shore; A D Sharrocks; R J Davis
Journal:  Science       Date:  1995-07-21       Impact factor: 47.728

7.  Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population.

Authors:  R S Nowakowski; S B Lewin; M W Miller
Journal:  J Neurocytol       Date:  1989-06

8.  The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth.

Authors:  P J Deutsch; Y Sun
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

9.  Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells.

Authors:  M Basille; B J Gonzalez; P Leroux; L Jeandel; A Fournier; H Vaudry
Journal:  Neuroscience       Date:  1993-11       Impact factor: 3.590

10.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

Authors:  O Boussif; F Lezoualc'h; M A Zanta; M D Mergny; D Scherman; B Demeneix; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  8 in total

1.  Treating brain tumors with PDE4 inhibitors.

Authors:  Rajarshi Sengupta; Tao Sun; Nicole M Warrington; Joshua B Rubin
Journal:  Trends Pharmacol Sci       Date:  2011-03-28       Impact factor: 14.819

2.  Differential expression pattern of ZAC in developing mouse and human pancreas.

Authors:  Xiaoyu Du; Marylene Rousseau; Houria Ounissi-Benkalha; Luc Marchand; Arif Jetha; Steven Paraskevas; Cynthia Goodyer; Constantin Polychronakos
Journal:  J Mol Histol       Date:  2011-02-09       Impact factor: 2.611

3.  Interaction of PACAP with Sonic hedgehog reveals complex regulation of the hedgehog pathway by PKA.

Authors:  Pawel Niewiadomski; Annie Zhujiang; Mary Youssef; James A Waschek
Journal:  Cell Signal       Date:  2013-07-18       Impact factor: 4.315

4.  Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures.

Authors:  Joseph R Cohen; Daniel Z Resnick; Pawel Niewiadomski; Hongmei Dong; Linda M Liau; James A Waschek
Journal:  BMC Cancer       Date:  2010-12-09       Impact factor: 4.430

5.  Homology modeling and molecular docking of human pituitary adenylate cyclase‑activating polypeptide I receptor.

Authors:  Lusheng Wu; Wenhua Guang; Xiaojia Chen; An Hong
Journal:  Mol Med Rep       Date:  2014-07-24       Impact factor: 2.952

Review 6.  Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.

Authors:  Jessica Lu; Sarah J Piper; Peishen Zhao; Laurence J Miller; Denise Wootten; Patrick M Sexton
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

7.  Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity.

Authors:  Janna Blechman; Gil Levkowitz
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-21       Impact factor: 5.555

Review 8.  Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.

Authors:  Viktoria Denes; Peter Geck; Adrienn Mester; Robert Gabriel
Journal:  J Clin Med       Date:  2019-09-18       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.